Faron Pharmaceuticals News and Activities

View the org chart displaying its 26 main executives

Most searched biographies at Faron Pharmaceuticals

• Juho Jalkanen, Director and Chief Executive Officer
• Tuomo Pätsi, Non-Executive Chairman of the Board
• George Golumbeski, Non-executive Director

Popular executive movements at Faron Pharmaceuticals

• George Golumbeski has joined the company as Non-executive Director  (posted on May 6 2026).
• Heikki Jouttijärvi has joined the company as Chief Technical Officer  (posted on March 26 2026).
• Yrjoe Wichmann, who is Chief Financial Officer will soon leave the company  (posted on December 1 2025).

Click here to view some more movements at Faron Pharmaceuticals

Create your alert
to follow the executive moves at Faron Pharmaceuticals.

Faron Pharmaceuticals has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Faron Pharmaceuticals

• Other Releases | Faron

Social media about Faron Pharmaceuticals

• Faron Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Faron Pharmaceuticals on LinkedIn, X (Twitter) & YouTube